PMC:7079862 / 42721-43628
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1410 | 589-597 | Species | denotes | MERS-CoV | Tax:1335626 |
| 1411 | 111-120 | Species | denotes | influenza | Tax:11520 |
| 1412 | 183-192 | Species | denotes | influenza | Tax:11520 |
| 1413 | 229-238 | Species | denotes | influenza | Tax:11520 |
| 1414 | 314-323 | Species | denotes | influenza | Tax:11520 |
| 1415 | 685-694 | Species | denotes | influenza | Tax:11520 |
| 1419 | 337-353 | Disease | denotes | viral infections | MESH:D001102 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T284 | 111-120 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
| T285 | 183-192 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
| T286 | 229-238 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
| T287 | 246-248 | Disease | denotes | he | http://purl.obolibrary.org/obo/MONDO_0017319 |
| T288 | 314-323 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
| T289 | 337-353 | Disease | denotes | viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
| T290 | 512-514 | Disease | denotes | he | http://purl.obolibrary.org/obo/MONDO_0017319 |
| T291 | 530-532 | Disease | denotes | he | http://purl.obolibrary.org/obo/MONDO_0017319 |
| T292 | 685-694 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T295 | 286-298 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | Organization |
| T296 | 533-536 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T297 | 542-543 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T298 | 578-584 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T265 | 567-577 | Chemical | denotes | antivirals | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T23 | 337-353 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infections |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T300 | 0-907 | Sentence | denotes | Dr. Hayden’s institution received funding from GlaxoSmithKline (Data Safety Monitoring Board [DSMB] member for influenza randomized-controlled trial [RCT]), Celltrion (DSMB chair for influenza RCT), and Vaccitech (DSMB chair for influenza RCTs); he received honoraria from World Health Organization (consultant on influenza and emerging viral infections) and the University of Alabama (Scientific Advisory Board member for National Institutes of Health-sponsored Antiviral Discovery and Development Consortium); he disclosed that he has been a non-paid consultant on antivirals active for MERS-CoV for Gilead Sciences, SAB Biotherapeutics, and Regeneron, and for multiple companies on influenza therapeutics; Cidara, Shionogi, Seqirus, and resTORbio have made charitable contributions to the Ford Haitian Orphanage and School for his consulting time; Shionogi and Roche have provided meeting travel support. |